drugset / Trial / NCT00797706
Phase I/II Dose Ranging CHRONSEAL® Study in Venous Leg Ulcers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate if the investigational medicinal product CHRONSEAL intended for future treatment of chronic venous leg ulcers is safe and tolerated and if it has an ulcer size reduction effect when administered to individuals suffering from venous leg ulcers.
Timeline
- Start
- 2008-11
- Primary completion
- 2010-03
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KP-dHGF | Protein / enzyme biologic | 1.4 g | Topical |
| Subject | KP-dHGF | Protein / enzyme biologic | 2.8 g | Topical |